Abstract:The genetic disease cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The CFTR anion channel is expressed in epithelial cells to promote fluid secretion, and in immune cells to regulate the immune response. People with CF experience intestinal inflammation and dysbiosis, characterized by decreased microbial diversity, loss of commensal bacteria, and an increase in pathogenic species. Currently, the impact of intestinal epithelial-specific CFTR loss versus global CFTR loss on intestinal inflammation and the fecal microbiome is unknown. We hypothesized that epithelial-specific Cftr knockout will induce intestinal dysbiosis and inflammation. Fecal pellets were collected using sterile technique from single-housed B6.Cg-Tg(Vil1-cre)-Cftrf10/f10 intestinal-specific Cftr knockout (iCftr KO) mice and wildtype (WT) littermates. Fecal calprotectin, a marker of inflammation, was measured via ELISA kit, and a DNA extraction kit was used to obtain fecal microbial DNA for subsequent 16S rRNA sequencing. These experimental endpoints were measured in iCftr KO and WT mice maintained on either a commercially available chow diet with an osmotic polyethylene glycol (PEG) laxative in their drinking water, or a nutritionally complete liquid diet (Peptamen) and tap water to prevent intestinal obstruction. Fecal calprotectin was significantly increased in iCftr KO mice compared to WT in both PEG (2.75±1.39μg/g WT, 19.86±3.97μg/g iCftr KO, n = 9 pairs, p = 0.001) and Peptamen-fed mice (12.04±2.83μg/g WT, 36.05±6.63μg/g iCftr KO, n = 9 pairs, p = 0.007). Measurement of fecal microbial α-diversity of WT and iCftr KO PEG mice revealed no significant difference in either Shannon H diversity (3.79±0.19 WT, 3.56±0.12 iCftr KO, n = 10 pairs, p = 0.273) or Chao-1 richness indices (202.9±12.8 WT, 184.5±8.68 iCftr KO, n = 10 pairs, p = 0.250). PERMANOVA results of β-diversity calculated using the Bray-Curtis dissimilarity demonstrated that the fecal microbiome of iCftr KO PEG mice were significantly different from WT PEG mice (n = 10 pairs, p = 0.0001, F = 6.511). iCftr KO PEG mice showed enrichment of several potential pathobionts, including several species from the genus Clostridium. Peptamen-fed iCftr KO mice had a significant decrease in α-diversity using both Shannon H diversity (3.58±0.08 WT, 2.797±0.17 iCftr KO, n = 10 pairs, p < 0.001) and Chao-1 richness indices (207.8±15.29 WT, 100.0±10.93 iCftr KO, n = 10 pairs, p < 0.001). PERMANOVA results for Peptamen-fed mice revealed a significant difference between the microbial composition of iCftr KO and WT mice (n = 10 pairs, p = 0.0001, F = 5.671). Peptamen-fed iCftr KO mice also had significant enrichment of several Clostridium species, including C. difficile. Based on the above data, we conclude that intestinal epithelial-specific loss of Cftr function is sufficient to induce intestinal inflammation and dysbiosis. Funding: Cystic Fibrosis Foundation grant CLARKE20G0, Crohn's and Colitis Foundation grant #693938 This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

CFTR Correctors and Antioxidants Partially Normalize Lipid Imbalance but not Abnormal Basal Inflammatory Cytokine Profile in CF Bronchial Epithelial Cells

Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lungs Is Not Resolved by CFTR Modulators

Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration

Changes in Essential Fatty Acids and Ileal Genes Associated with Metabolizing Enzymes and Fatty Acid Transporters in Rodent Models of Cystic Fibrosis

Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis

Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice

Deletion of cftr Leads to an Excessive Neutrophilic Response and Defective Tissue Repair in a Zebrafish Model of Sterile Inflammation

Systemic effects of cystic fibrosis transmembrane conductance regulator (CFTR) modulators on the blood proteome

Cystic Fibrosis Reprograms Airway Epithelial IL-33 Release and Licenses IL-33 Dependent Inflammation

Fecal Dysbiosis and Inflammation in Intestinal-Specific Cftr Knockout Mice

Lipoxin A4 and Platelet Activating Factor Are Involved in E. coli or LPS-Induced Lung Inflammation in CFTR-Deficient Mice

Ozone Stress Down-Regulates the Expression of Cystic Fibrosis Transmembrane Conductance Regulator in Human Bronchial Epithelial Cells

Specialized pro-resolving mediator Resolvin E1 corrects the altered cystic fibrosis nasal epithelium cilia beating dynamics

Effect of CFTR Modulators on Oxidative Stress and Autophagy in Non-CFTR-Expressing Cells

Akt-driven TGF-β and DKK1 Secretion Impairs F508del CF Airway Epithelium Polarity

Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis

Dysfunction of CFTR in Alveolar Macrophages and Neutrophils Propagates Production of Proinflammatory Cytokines and Exacerbates Acute Lung Injury in Mice

Akt-driven TGF-β and DKK1 Secretion Impairs F508del Cystic Fibrosis Airway Epithelium Polarity

Cross-talk between CFTR and sphingolipids in cystic fibrosis

Dysregulation of the Arachidonic Acid Pathway in Cystic Fibrosis: Implications for Chronic Inflammation and Disease Progression

CFTR negatively regulates cyclooxygenase-2-PGE(2) positive feedback loop in inflammation.